SCHEMBL22346868

SCHEMBL22346868

O=C(O)c1ccc2cc(Cl)c(F)cc2n1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MGAM O43451 1/20 0.47
▸ KMO O15229 4/20 0.42
▸ NR1H4 Q96RI1 1/20 0.40
▸ KEAP1 Q14145 1/20 0.39
▸ NFE2L2 Q16236 1/20 0.39
▸ KDM4E B2RXH2 3/20 0.38
▸ ALOX15 P16050 1/20 0.38
▸ TSHR P16473 1/20 0.38
▸ ACMSD Q8TDX5 1/20 0.38
▸ TDP1 Q9NUW8 1/20 0.38
▸ PRKAG1 P54619 1/20 0.38
▸ PRKAA1 Q13131 1/20 0.38
▸ PRKAB1 Q9Y478 1/20 0.38
▸ KMT2A Q03164 3/20 0.38
▸ MEN1 O00255 2/20 0.38
▸ HSD17B14 Q9BPX1 2/20 0.38
▸ GRM2 Q14416 1/20 0.38
▸ STING1 Q86WV6 1/20 0.38
▸ ALPL P05186 1/20 0.37
▸ LMNA P02545 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20772073 0.86 MGAM (0.53) MGAMKMOKDM4EALOX15TSHR
SCHEMBL2715968 0.86 MGAM (0.53) MGAMKMOKDM4EALOX15TSHR
SCHEMBL18191203 0.80 MGAM (0.47) MGAMKDM4EALOX15TSHRACMSD
SCHEMBL12405037 0.80 MGAM (0.63) MGAMKDM4EALOX15TSHRACMSD
SCHEMBL29411763 0.78 MGAM (0.49) MGAMKDM4EALOX15TSHRACMSD
SCHEMBL26606765 0.78 MGAM (0.49) MGAMKDM4EALOX15TSHRACMSD
SCHEMBL9220609 0.78 MGAM (0.61) MGAMKDM4EALOX15TSHRACMSD
SCHEMBL22777233 0.75 MGAM (0.58) MGAMKMOKDM4EALOX15TSHR
SCHEMBL7170725 0.75 MGAM (0.58) MGAMKMOKEAP1KDM4EALOX15
SCHEMBL29527233 0.75 MGAM (0.58) MGAMKMOKDM4EALOX15TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11958840-B2 Compounds, compositions and methods DENALI THERAPEUTICS INC. (US) 2024-04-16 — — US disclosed
US-20230114472-A1 COMPOUNDS, COMPOSITIONS AND METHODS DENALI THERAPEUTICS INC. 2023-04-13 — — US disclosed
US-11306077-B2 Compounds, compositions and methods DENALI THERAPEUTICS INC. (US) 2022-04-19 — — US disclosed
EP-3923935-A1 COMPOUNDS, COMPOSITIONS AND METHODS Denali Therapeutics Inc. (US) 2021-12-22 — — EP disclosed
CN-113518618-A Compounds, compositions and methods 戴纳立制药公司 2021-10-19 — — CN disclosed
US-20210292311-A1 COMPOUNDS, COMPOSITIONS AND METHODS DENALI THERAPEUTICS INC. 2021-09-23 — — US disclosed
WO-2020168011-A1 COMPOUNDS, COMPOSITIONS AND METHODS DENALI THERAPEUTICS INC. (US) 2020-08-20 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11958840-B2 Compounds, compositions and methods EIF4EBP1, EIF4B, EIF4E MGAM 4178/4885KMO 4531/4885NR1H4 1736/4885
US-20230114472-A1 COMPOUNDS, COMPOSITIONS AND METHODS EIF4EBP1, EIF4B, EIF4E MGAM 4178/4885KMO 4531/4885NR1H4 1736/4885
US-20210292311-A1 COMPOUNDS, COMPOSITIONS AND METHODS EIF4EBP1, EIF4B, EIF4E MGAM 4178/4885KMO 4531/4885NR1H4 1736/4885
US-11306077-B2 Compounds, compositions and methods EIF4EBP1, EIF4B, EIF4E MGAM 4178/4885KMO 4531/4885NR1H4 1736/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback